The Blue KC Medical and Pharmacy Management Committee reviews and maintains the Prescription Drug List (PDL). The Committee, consisting of practicing physicians and pharmacists in the Kansas City area, holds quarterly meetings to evaluate new drug therapies and review drug utilization issues. Medications are evaluated based on drug safety and costs.
The July 1, 2022, PDL change only applies to groups that are on the Preferred and Premium formulary (this does NOT impact small group ACA). Group-specific benefit exceptions may apply.
Updates affecting the Preferred formulary
Please review the following communications and resources for Preferred formulary changes:
- Preferred Prescription Drug List Updates
- Communication to Preferred group benefits managers
- Impacted members will receive a letter
Updates affecting the Premium formulary
Please review the following communications and resources for Premium formulary changes: